Funder
a Clinical Evidence Council (CEC) grant from Baxter Healthcare Corporation (Deerfield, IL)
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl. 2006:S104–9.
2. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66:408–18.
3. Davies SJ, Mushahar L, Yu Z, Lambie M. Determinants of peritoneal membrane function over time. Semin Nephrol. 2011;31:172–82.
4. Boulanger E. Peritoneal and systemic inflammation: the benefits of using biocompatible peritoneal dialysis fluids. Perit. Dial. Int. J. Int. Soc. Perit. Dial. 2008;28:28–31.
5. Li PKT, Culleton BF, Ariza A, Do J-Y, Johnson DW, Sanabria M, et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J. Am. Soc. Nephrol. JASN. 2013;24:1889–900.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献